Advertisement
Screener

Journey Medical Corp (DERM) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Journey Medical Corp Financing Cash Flow

Journey Medical Corp (DERM) reported Financing Cash Flow of $378.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-12

  • Journey Medical Corp net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $158.00K, a 4.24% decline year-over-year.
  • Journey Medical Corp net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $220.00K, a 93.88% decline year-over-year.
  • Journey Medical Corp net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $5.43M, a 48.90% decline year-over-year.
  • Journey Medical Corp net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $7.04M.
  • Journey Medical Corp net cash provided by (used in) financing activities for fiscal 2025 was $16.23M, a 4.51% decline from fiscal 2024.
  • Journey Medical Corp net cash provided by (used in) financing activities for fiscal 2024 was $16.99M.
  • Journey Medical Corp net cash provided by (used in) financing activities for fiscal 2023 was -$4.80M, a 129.19% decline from fiscal 2022.
  • Journey Medical Corp net cash provided by (used in) financing activities for fiscal 2022 was $16.46M, a 68.96% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30$158.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$378.00K
10-Q · filed 2026-08-12
$5.80M
derived: sum of 3 quarters · filed 2026-08-12
$12.84M
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$220.00K
10-Q · filed 2026-05-13
$5.65M
derived: sum of 2 quarters · filed 2026-05-13
$12.68M
derived: sum of 3 quarters · filed 2026-05-13
$12.85M
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$5.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$12.46M
derived: sum of 2 quarters · filed 2026-03-26
$12.63M
derived: sum of 3 quarters · filed 2026-08-12
$16.23M
10-K · filed 2026-03-26
2025-09-30$7.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$7.20M
derived: sum of 2 quarters · filed 2026-08-12
$10.80M
10-Q · filed 2025-11-12
$21.42M
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$165.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$3.76M
10-Q · filed 2026-08-12
$14.38M
derived: sum of 3 quarters · filed 2026-08-12
$14.09M
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$3.60M
10-Q · filed 2026-05-13
$14.22M
derived: sum of 2 quarters · filed 2026-05-13
$13.92M
derived: sum of 3 quarters · filed 2026-05-13
$18.95M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$10.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26
$10.32M
derived: sum of 2 quarters · filed 2026-03-26
$15.36M
derived: sum of 3 quarters · filed 2026-03-26
$16.99M
10-K · filed 2026-03-26
2024-09-30-$294.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$4.74M
derived: sum of 2 quarters · filed 2025-11-12
$6.37M
10-Q · filed 2025-11-12
$25.58M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$5.03M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$6.67M
10-Q · filed 2025-08-12
$25.88M
derived: sum of 3 quarters · filed 2025-08-12
$14.90M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$1.64M
10-Q · filed 2025-05-15
$20.85M
derived: sum of 2 quarters · filed 2025-05-15
$9.87M
derived: sum of 3 quarters · filed 2025-05-15
-$3.22M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$19.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$8.23M
derived: sum of 2 quarters · filed 2025-03-27
-$4.86M
derived: sum of 3 quarters · filed 2025-03-27
-$4.80M
10-K · filed 2025-03-27
2023-09-30-$10.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$24.07M
derived: sum of 2 quarters · filed 2024-11-12
-$24.01M
10-Q · filed 2024-11-12
-$23.07M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$13.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$13.04M
10-Q · filed 2024-08-13
-$12.09M
derived: sum of 3 quarters · filed 2024-08-13
-$8.06M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$52.00K
10-Q · filed 2024-05-14
$1.00M
derived: sum of 2 quarters · filed 2024-05-14
$5.03M
derived: sum of 3 quarters · filed 2024-05-14
$5.14M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$948.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$4.98M
derived: sum of 2 quarters · filed 2024-03-29
$5.09M
derived: sum of 3 quarters · filed 2024-03-29
$16.46M
10-K · filed 2024-03-29
2022-09-30$4.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13
$4.14M
derived: sum of 2 quarters · filed 2023-11-13
$15.51M
10-Q · filed 2023-11-13
$47.31M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$111.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$11.48M
10-Q · filed 2023-08-10
$43.27M
derived: sum of 3 quarters · filed 2023-08-10
$54.49M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$11.37M
10-Q · filed 2023-05-22
$43.16M
derived: sum of 2 quarters · filed 2023-05-22
$54.38M
derived: sum of 3 quarters · filed 2023-05-22
$54.99M
derived: sum of 4 quarters · filed 2023-05-22
2021-12-31$31.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
$43.01M
derived: sum of 2 quarters · filed 2023-03-31
$43.63M
derived: sum of 3 quarters · filed 2023-03-31
$53.02M
10-K · filed 2023-03-31
2021-09-30$11.21M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
$11.83M
derived: sum of 2 quarters · filed 2022-11-10
$21.22M
10-Q · filed 2022-11-10
2021-06-30$616.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$10.01M
10-Q · filed 2022-08-09
2021-03-31$9.39M
10-Q · filed 2022-05-10
2020-12-31-$487.00K
10-K · filed 2022-03-28